GOSSAMER BIO INC (GOSS) Stock Analyst Earnings Estimates
NASDAQ:GOSS - Nasdaq - US38341P1021 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -81.17% | N/A 154.71% | N/A 96.95% | N/A 90.04% | N/A 75.59% | N/A 95.43% | N/A -8.31% | N/A 24.56% | |||||||||
| EBITDA YoY % growth | -80K | -1.15M -1,337.50% | -99.03M -8,511.30% | -181.62M -83.40% | -209.17M -15.17% | -214.3M -2.45% | -216.69M -1.12% | -172.152M 20.55% | N/A 68.13% | N/A -181.83% | N/A 71.69% | N/A 92.54% | N/A 2,484.38% | N/A 111.92% | N/A | N/A | N/A | |
| EBIT YoY % growth | -80K | -1.15M -1,337.50% | -99.33M -8,537.39% | -182.54M -83.77% | -210.58M -15.36% | -216.04M -2.59% | -218.52M -1.15% | -173.759M 20.48% | N/A 63.65% | N/A -168.93% | N/A 24.72% | N/A 52.07% | N/A 130.01% | N/A 672.03% | N/A 189.85% | N/A -20.91% | N/A 36.13% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -3.33 29.75% | -3.55 -6.61% | -3.12 12.11% | -2.74 12.18% | -1.39 49.27% | N/A 79.27% | N/A -151.50% | N/A 33.85% | N/A 68.51% | N/A 145.95% | N/A 426.47% | N/A 63.41% | N/A 52.56% | N/A 12.61% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 18.45% | -0.19 -0.93% | -0.19 -185.24% | -0.19 -34.37% | -0.16 5.40% | -0.18 7.18% | -0.18 5.09% | -0.14 24.36% | -0.10 40.50% |
| Revenue Q2Q % growth | 6.971M | 3.631M | 3.631M -96.21% | 3.631M -61.70% | 10.685M 53.28% | -100.00% | -100.00% | 20.4M 461.83% | 48.379M 352.77% |
| EBITDA Q2Q % growth | -18.972M 49.30% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -39.204M -0.45% | -45.997M -9.62% | -46.751M -189.76% | -48.635M -43.39% | -50.092M -27.77% | -49.807M -8.28% | -50.755M -8.56% | -30.797M 36.68% | -3.851M 92.31% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.14 33.33% | -0.15 | 0.01 | 7.13% |
| Q2 2024 Q2Q % growth | 0.22 148.89% | 0.23 | -0.01 | -5.81% |
| Q1 2024 Q2Q % growth | -0.19 63.46% | -0.19 | 0.00 | 1.50% |
| Q4 2023 Q2Q % growth | -0.21 64.41% | -0.21 | 0.00 | 0.96% |
| Q3 2023 Q2Q % growth | -0.21 67.69% | -0.26 | 0.05 | 19.45% |
| Q2 2023 Q2Q % growth | -0.45 39.19% | -0.50 | 0.05 | 9.78% |
| Q1 2023 Q2Q % growth | -0.52 31.58% | -0.54 | 0.02 | 3.74% |
| Q4 2022 Q2Q % growth | -0.59 20.27% | -0.64 | 0.05 | 7.17% |
| Q3 2022 Q2Q % growth | -0.65 18.75% | -0.65 | 0.00 | -0.34% |
| Q2 2022 Q2Q % growth | -0.74 7.50% | -0.71 | -0.03 | -3.72% |
| Q1 2022 Q2Q % growth | -0.76 2.56% | -0.78 | 0.02 | 2.81% |
| Q4 2021 Q2Q % growth | -0.74 15.91% | -0.76 | 0.02 | 2.40% |
| Q3 2021 Q2Q % growth | -0.80 | -0.80 | 0.00 | 0.09% |
| Q2 2021 Q2Q % growth | -0.80 20.00% | -0.77 | -0.03 | -3.54% |
| Q1 2021 Q2Q % growth | -0.78 10.34% | -0.77 | -0.01 | -1.62% |
| Q4 2020 Q2Q % growth | -0.88 1.12% | -0.81 | -0.07 | -9.21% |
| Q3 2020 Q2Q % growth | -0.80 | -0.87 | 0.07 | 8.09% |
| Q2 2020 Q2Q % growth | -1.00 -35.14% | -0.88 | -0.12 | -13.56% |
| Q1 2020 Q2Q % growth | -0.87 3.33% | -0.82 | -0.05 | -6.62% |
| Q4 2019 Q2Q % growth | -0.89 | -0.88 | -0.01 | -1.46% |
| Q3 2019 Q2Q % growth | -0.80 | -0.71 | -0.09 | -12.85% |
| Q2 2019 Q2Q % growth | -0.74 | -0.57 | -0.17 | -29.55% |
| Q1 2019 Q2Q % growth | -0.90 | -0.67 | -0.23 | -34.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 9.48M | 7.854M | 1.626M | 20.70% |
| Q2 2024 Q2Q % growth | 95.842M | 116.57M | -20.728M | -17.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 13.21% | 0% | -5.94% |
| Revenue | 0% | N/A | 0% | -3.48% |